TCL Archive FDA Says ImClone Data Insufficient To Evaluate Colorectal Cancer Drug C225. January 4, 2002
TCL Archive New Government-Wide Regulatory Policy Set For Carcinogens; Industry Group Says They are Not Scientific October 5, 1979
TCL Archive Abraxane-Gemcitabine Combination Extends Overall Survival in Phase III Trial January 31, 2014